RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure

Journal of Clinical Investigation

Volumn 126, Issue 1, 2016, Pages 195-206

  Gao, Chen ^a   Ren, Shuxun ^a   Lee, Jae Hyung ^a,b,e   Qiu, Jinsong ^c   Chapski, Douglas J ^a   Rau, Christoph D ^a   Zhou, Yu ^c   Abdellatif, Maha ^d   Nakano, Astushi ^a,b   Vondriska, Thomas M ^a   Xiao, Xinshu ^a,b   Fu, Xiang Dong ^c   Chen, Jau Nian ^a,b   Wang, Yibin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; MYOCYTE ENHANCER FACTOR 2; RBFOX1 PROTEIN; RNA ISOFORM; TRANSCRIPTOME; UNCLASSIFIED DRUG; RBFOX1 PROTEIN, HUMAN; RNA BINDING PROTEIN; RNA SPLICING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CARDIAC MATURATION; CONTROLLED STUDY; EVALUATION STUDY; GENE EXPRESSION; GENE SWITCHING; GENETIC VARIABILITY; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HUMAN; HUMAN TISSUE; MALE; MATURATION; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RNA SPLICING; ZEBRA FISH; ANIMAL; CARDIOMEGALY; GENETICS; PHYSIOLOGY;

ANIMALS; CARDIOMEGALY; HEART FAILURE; HUMANS; MEF2 TRANSCRIPTION FACTORS; MICE; RNA SPLICING; RNA SPLICING FACTORS; RNA-BINDING PROTEINS; TRANSCRIPTOME;

EID: 84956699222     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI84015     Document Type: Article

References (52)

1. Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol. 2009;10(11):741-754.
2. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40(12):1413-1415.
3. Wang Z, Gerstein M, Snyder M. RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57-63.
4. Hallegger M, Llorian M, Smith CW. Alternative splicing: global insights. FEBS J. 2010;277(4):856-866.
5. Raghavachari N, et al. A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease. BMC Med Genomics. 2012;5(1):28-48.
6. Honda A, Valogne Y, Bou Nader M, Brechot C, Faivre J. An intron-retaining splice variant of human cyclin A2, expressed in adult differentiated tissues, induces a G1/S cell cycle arrest in vitro. PLoS One. 2012;7(6):e39249.
7. Gang H, et al. A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes. Circ Res. 2011;108(9):1084-1092.
8. Yae T, et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun. 2012;3:883.
9. Yang J, et al. RBM24 is a major regulator of muscle-specific alternative splicing. Dev Cell. 2014;31(1):87-99.
10. Poon KL, et al. RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility. Cardiovasc Res. 2012;94(3):418-427.
11. Ramchatesingh J, Zahler AM, Neugebauer KM, Roth MB, Cooper TA. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol. 1995;15(9):4898-4907.
12. Xu X, et al. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell. 2005;120(1):59-72.
13. Ding JH, et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J. 2004;23(4):885-896.
14. Mirtschink P, et al. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature. 2015;522(7557):444-449.
15. Ye J, et al. hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function. Proc Natl Acad Sci U S A. 2015;112(23):E3020-E3029.
16. Maatz H, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest. 2014;124(8):3419-3430.
17. Guo W, Pleitner JM, Saupe KW, Greaser ML. Pathophysiological defects and transcriptional profiling in the RBM20-/-rat model. PLoS One. 2013;8(12):e84281.
18. Guo W, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012;18(5):766-773.
19. Methawasin M, et al. Experimentally increasing titin compliance in a novel mouse model attenuates the Frank-Starling mechanism but has a beneficial effect on diastole. Circulation. 2014;129(19):1924-1936.
20. Griswold AJ, et al. Targeted massively parallel sequencing of autism spectrum disorder-associated genes in a case control cohort reveals rare loss-offunction risk variants. Mol Autism. 2015;6(1):43.
21. Pedrotti S, et al. The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function. Hum Mol Genet. 2015;24(8):2360-2374.
22. Frese KS, et al. RNA splicing regulated by RBFOX1 is essential for cardiac function in zebrafish. J Cell Sci. 2015;128(16):3030-3040.
23. Lee JH, et al. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. 2011;109(12):1332-1341.
24. Xiao X, Wang Z, Jang M, Burge CB. Coevolutionary networks of splicing cis-regulatory elements. Proc Natl Acad Sci U S A. 2007;104(47):18583-18588.
25. Refaat MM, et al. Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm. 2012;9(3):390-396.
26. Warf MB, Berglund JA. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA. 2007;13(12):2238-2251.
27. Wei C, et al. Repression of the central splicing regulator RBFox2 is functionally linked to pressure overload-induced heart failure [published online ahead of print March 3, 2015]. Cell Rep. doi:10.1016/j.celrep.2015.02.013.
28. Sayed D, He M, Yang Z, Lin L, Abdellatif M. Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy. J Biol Chem. 2013;288(4):2546-2558.
29. Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 1997;276(5317):1404-1407.
30. Lu J, McKinsey TA, Zhang CL, Olson EN. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 2000;6(2):233-244.
31. Sebastian S, et al. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation. Genes Dev. 2013;27(11):1247-1259.
32. Jin Y, et al. A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J. 2003;22(4):905-912.
33. Boutz PL, et al. and Black DL. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 2007;21(13):1636-1652.
34. Harmon AW, Nakano A. Nkx2-5 lineage tracing visualizes the distribution of second heart field-derived aortic smooth muscle. Genesis. 2013;51(12):862-869.
35. Gehman LT, et al. The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nat Genet. 2011;43(7):706-711.
36. Gallagher TL, et al. Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. Dev Biol. 2011;359(2):251-261.
37. James J, et al. Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation. 2005;111(18):2339-2346.
38. Li H, Qiu J, Fu XD. RASL-seq for massively parallel and quantitative analysis of gene expression. Curr Protoc Mol Biol. 2012;Chapter 4:Unit 4.13.1-9.
39. de la Grange P, Gratadou L, Delord M, Dutertre M, Auboeuf D. Splicing factor and exon profiling across human tissues. Nucleic Acids Res. 2010;38(9):2825-2838.
40. Sultan M, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science. 2008;321(5891):956-960.
41. Bland CS, et al. Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res. 2010;38(21):7651-7664.
42. Li S, Guo W, Dewey CN, Greaser ML. Rbm20 regulates titin alternative splicing as a splicing repressor. Nucleic Acids Res. 2013;41(4):2659-2672.
43. Linke WA, Bucker S. King of hearts: A splicing factor rules cardiac proteins. Nat Med. 2012;18(5):660-661.
44. Dasgupta T, Ladd AN. The importance of CELF control: molecular and biological roles of the CUGBP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA. 2012;3(1):104-121.
45. Koshelev M, Sarma S, Price RE, Wehrens XH, Cooper TA. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum Mol Genet. 2010;19(6):1066-1075.
46. Kalsotra A, Wang K, Li PF, Cooper TA. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 2010;24(7):653-658.
47. Singh RK, et al. Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. Mol Cell. 2014;55(4):592-603.
48. Runfola V, Sebastian S, Dilworth FJ, Gabellini D. Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation. J Cell Sci. 2015;128(4):631-637.
49. Ahuja P, et al. Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation. 2013;127(19):1957-1967.
50. Lee JH, et al. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. 2011;109(12):1332-1341.
51. Kalsotra A, et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A. 2008;105(51):20333-20338.
52. Nicol JW, Helt GA, Blanchard SG, Raja A, Loraine AE. The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics. 2009;25(20):2730-2731.